Brand Story · Since 2023
AOWEISIAOWEISI
Founded in 2023, AOWEISI (Fujian) Cell Biology Technology Co., Ltd. focuses on s…
Corporate Vision
To become a world-class supplier of skincare, women's intimate care, and nasal care products, empowering health and beauty through synthetic biology exosome technology.
“Not just beauty, but true health.”
Mission
To provide global consumers with safe, effective, and affordable regenerative products—not only 'making people more beautiful' but also 'making people healthier'.
Core Highlights
Three Product Lines
Skincare (AOWEISI SKIN), Women's Intimate Care (AOWEISI FEM), Nasal Care (AOWEISI AIR).
Tech Platform
Synthetic biology exosomes and lyophilization, strict quality control and scalable production.
Market Positioning
Focused on skincare, intimate care, and nasal care, building the brand on quality and science.
Quality Assurance
Lyophilized formulations, proper storage and usage instructions, reliable quality.
R&D & Industrialization
1970s–2000s
Basic Research
From stem cell and molecular research to fast-acting preparations.
2000–2010
Exosome Establishment
Systematic exosome research, establishing its status as a core effector factor.
2010–2023
Tech Maturity
Exosome synthetic biology and lyophilization process maturity.
2023–Present
Product Launch
Three product lines launched: skincare essence, intimate care essence, and nasal care spray.
Founder Team Advantages
The core team consists of top biomedical PhDs, international aesthetic industry executives, and capital operation experts, possessing comprehensive capabilities in technology + industry + medical + capital.
Possessing integrated capabilities across technology, industry, medicine, and capital. We drive rapid industrialization in skincare/aesthetics and accelerate medical translation/commercialization of respiratory regenerative therapeutics.
